151 related articles for article (PubMed ID: 10718331)
1. Texaphyrins: new drugs with diverse clinical applications in radiation and photodynamic therapy.
Sessler JL; Miller RA
Biochem Pharmacol; 2000 Apr; 59(7):733-9. PubMed ID: 10718331
[TBL] [Abstract][Full Text] [Related]
2. In vivo photodynamic therapy with the new near-IR absorbing water soluble photosensitizer lutetium texaphyrin and a high intensity pulsed light delivery system.
Kostenich G; Orenstein A; Roitman L; Malik Z; Ehrenberg B
J Photochem Photobiol B; 1997 May; 39(1):36-42. PubMed ID: 9210320
[TBL] [Abstract][Full Text] [Related]
3. Phototherapy of cancer and atheromatous plaque with texaphyrins.
Woodburn KW; Fan Q; Kessel D; Wright M; Mody TD; Hemmi G; Magda D; Sessler JL; Dow WC; Miller RA; Young SW
J Clin Laser Med Surg; 1996 Oct; 14(5):343-8. PubMed ID: 9612202
[TBL] [Abstract][Full Text] [Related]
4. In vivo animal studies with gadolinium (III) texaphyrin as a radiation enhancer.
Miller RA; Woodburn K; Fan Q; Renschler MF; Sessler JL; Koutcher JA
Int J Radiat Oncol Biol Phys; 1999 Nov; 45(4):981-9. PubMed ID: 10571206
[TBL] [Abstract][Full Text] [Related]
5. Motexafin gadolinium: gadolinium (III) texaphyrin, gadolinium texaphyrin, Gd-Tex, GdT2B2, PCI 0120.
Drugs R D; 2004; 5(1):52-7. PubMed ID: 14725495
[TBL] [Abstract][Full Text] [Related]
6. Photodynamic therapy: applications in atherosclerotic vascular disease with motexafin lutetium.
Chou TM; Woodburn KW; Cheong WF; Lacy SA; Sudhir K; Adelman DC; Wahr D
Catheter Cardiovasc Interv; 2002 Nov; 57(3):387-94. PubMed ID: 12410519
[TBL] [Abstract][Full Text] [Related]
7. Photodynamic therapy with motexafin lutetium (Lu-Tex) reduces experimental graft coronary artery disease.
Yamaguchi A; Woodburn KW; Hayase M; Hoyt G; Robbins RC
Transplantation; 2001 Jun; 71(11):1526-32. PubMed ID: 11435960
[TBL] [Abstract][Full Text] [Related]
8. Reduction of vein graft disease using photodynamic therapy with motexafin lutetium in a rodent isograft model.
Yamaguchi A; Woodburn KW; Hayase M; Robbins RC
Circulation; 2000 Nov; 102(19 Suppl 3):III275-80. PubMed ID: 11082401
[TBL] [Abstract][Full Text] [Related]
9. A phase I single-dose trial of gadolinium texaphyrin (Gd-Tex), a tumor selective radiation sensitizer detectable by magnetic resonance imaging.
Rosenthal DI; Nurenberg P; Becerra CR; Frenkel EP; Carbone DP; Lum BL; Miller R; Engel J; Young S; Miles D; Renschler MF
Clin Cancer Res; 1999 Apr; 5(4):739-45. PubMed ID: 10213207
[TBL] [Abstract][Full Text] [Related]
10. Clinical trials referral resource. Clinical trials with gadolinium-texaphyrin and lutetium-texaphyrin.
Ivy SP; Blatner G; Cheson BD
Oncology (Williston Park); 1999 May; 13(5):671, 674-6. PubMed ID: 10356686
[No Abstract] [Full Text] [Related]
11. Motexafin lutetium (Pharmacyclics).
Yeung PF
IDrugs; 2001 Mar; 4(3):351-9. PubMed ID: 16025394
[TBL] [Abstract][Full Text] [Related]
12. Photosensitizers in photodynamic therapy.
Levy JG
Semin Oncol; 1994 Dec; 21(6 Suppl 15):4-10. PubMed ID: 7992105
[TBL] [Abstract][Full Text] [Related]
13. Photodynamic therapy for age-related macular degeneration.
Beck RW
Am J Ophthalmol; 2004 Sep; 138(3):513; author reply 513-4. PubMed ID: 15364257
[No Abstract] [Full Text] [Related]
14. Photodynamic therapy for age-related macular degeneration: a candid appraisal.
Sternberg P; Lewis H
Am J Ophthalmol; 2004 Mar; 137(3):483-5. PubMed ID: 15013872
[No Abstract] [Full Text] [Related]
15. Photodynamic therapy for neovascular age-related macular degeneration.
Wormald R; Evans J; Smeeth L; Henshaw K
Cochrane Database Syst Rev; 2003; (2):CD002030. PubMed ID: 12804420
[TBL] [Abstract][Full Text] [Related]
16. [Photodynamic therapy and age-related macular degeneration in 2000].
Desmettre T; Cohen SY; Mordon S
J Fr Ophtalmol; 2001 Jan; 24(1):82-93. PubMed ID: 11240477
[No Abstract] [Full Text] [Related]
17. Vascular-targeted photodynamic therapy in the treatment of neovascular age-related macular degeneration: Clinical perspectives.
Kawczyk-Krupka A; Bugaj AM; Potempa M; Wasilewska K; Latos W; SieroĊ A
Photodiagnosis Photodyn Ther; 2015 Jun; 12(2):161-75. PubMed ID: 25843911
[TBL] [Abstract][Full Text] [Related]
18. Photodynamic therapy with verteporfin (Visudyne) for macular degeneration.
Med Lett Drugs Ther; 2000 Sep; 42(1086):81-2. PubMed ID: 10980812
[No Abstract] [Full Text] [Related]
19. Photodynamic therapy with verteporfin: a new treatment in ophthalmology.
Michels S; Schmidt-Erfurth U
Semin Ophthalmol; 2001 Dec; 16(4):201-6. PubMed ID: 15513441
[TBL] [Abstract][Full Text] [Related]
20. Using light to treat age-related macular degeneration.
Nosek J
Nurs Times; 2005 Nov 15-21; 101(46):30-3. PubMed ID: 16315801
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
